ArticleClinical trials (London, England)2014
Increasing Asian American participation in clinical trials by addressing community concerns.
Article in Clinical trials (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.
- Impact of sociodemographic determinants on enrollment into contemporary lymphoma clinical trials: a systematic review.The oncologist · 2025Pooled it
- Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis.JAMA internal medicine · 2023Pooled it
- Trial
- Personalized survival prediction in young Asian American breast cancer.Gland surgery · 2026Article
- Navigating the Path to Inclusion: Understanding Barriers and Facilitators to Clinical Trial Participation Among Chinese Older Adults in the United States with Multimorbidity.Journal of general internal medicine · 2025Article
- Demographic comparison of subjects in FDA approval trials in the United States to disorder specific demographics using Real World Data.Contemporary clinical trials communications · 2024Article
- Vietnamese Americans' level of trust in sources of information and willingness to participate in COVID-19 clinical trials.Journal of clinical and translational science · 2024Article
- Vietnamese American Perspectives on Engagement in an Aging-Focused Research Registry.Dementia and geriatric cognitive disorders · 2024Article
- Using community-based geographical information system (GIS) to recruit older Asian Americans in an Alzheimer's disease study.BMJ open · 2023Review
- Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials.Frontiers in oncology · 2023Article
- Overcoming racial disparities in cancer clinical trial enrollment of Asians and Native Hawaiians.Contemporary clinical trials communications · 2022Article
- Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure Collaboratory.JAMA cardiology · 2022Article
- Identifying Facilitators and Barriers to Increasing COVID-19 Vaccination and Trial Participation in Vaccinated Vietnamese Americans.Health equity · 2022Article
- Translation and validation of the greek version of a questionnaire measuring patient views on participation in clinical trials.BMC health services research · 2021Article
- Achieving Equity in Asian American Healthcare: Critical Issues and Solutions.Journal of Asian health · 2021Article
- Recruitment of Asian Americans with Schizophrenia Spectrum Disorder for Research Participation: Barriers, Strategies, and Outcomes.Community mental health journal · 2021Observational
- Asian Americans are less willing than other racial groups to participate in health research.Journal of clinical and translational science · 2019Article
- Increasing Asian American participation in clinical trials by addressing community concerns.Clinical trials (London, England) · 2014Article
- Factors associated with willingness to participate in biospecimen research among Chinese Americans.Biopreservation and biobanking · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
Background Asian Americans are underrepresented in clinical trials, but little is known about the factors that contribute to clinical trial participation in this population. Purpose The purpose of this study was to identify knowledge, barriers, facilitators, and cultural influences on participating in clinical trials among three Asian American ethnic groups. Concurrently, we sought to identify mechanisms and messages to facilitate dissemination of information and to identify strategies to promote clinical trial participation in this population. Methods Eight focus groups were conducted (n = 103) with Chinese (four groups), Korean (two groups), and Vietnamese (two groups) Americans. Each group was conducted with a moderator and a translator using a standardized guide. Results Participants discuss the benefits of contributing to science, future generations, and their families by being in clinical trials. Some participants think clinical trials would give hope to those with terminal illnesses. A doctor's recommendation, being sick, and needing more options for treatment are motivators for Asian Americans. Having some guarantee of treatment effectiveness and lack of side effects facilitates participation. Cultural or religious beliefs are not believed to prevent clinical trial participation. Limitations This qualitative, two-site study included three Asian American ethnic groups and is not meant to establish prevalence of beliefs. Conclusion Asian Americans need more information about clinical trials and their benefits to science and the larger community. Health-care providers can play pivotal roles in enhancing recruitment of Asian Americans. Basing recruitment goals on percentage representation in most US geographic areas does not provide sufficient numbers to allow for analysis of minorities like Asian American groups. The discovery of important group-specific harms and benefits depends on greater participation of racial/ethnic subgroups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.